Purple Biotech Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PPBT research report →
About the company
Purple Biotech Ltd. , a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1).
- CEO
- Gil Efron
- IPO
- 2015
- Employees
- 9
- HQ
- Rehovot, IL
Price Chart
- Market Cap
- $234.74K
- P/E
- -0.01
- P/S
- 0.00
- P/B
- 0.63
- EV/EBITDA
- 0.49
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -123.47%
- ROIC
- -297.05%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,386,000 · -264.45%
- EPS
- $-11080.00 · -24967.87%
- Op Income
- $-27,458,000
- FCF YoY
- 61.44%
- 52W High
- $29.00
- 52W Low
- $1.42
- 50D MA
- $3.05
- 200D MA
- $5.35
- Beta
- -0.54
- Avg Volume
- 307.33K
Get TickerSpark's AI analysis on PPBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Rock Simcha | other | 0 |
| Mar 18, 26 | Rock Simcha | other | 2,650,000 |
| Mar 18, 26 | Zilberberg Suzana | other | 0 |
| Mar 18, 26 | Zilberberg Suzana | other | 2,650,000 |
| Mar 18, 26 | Agmon Ido | other | 0 |
| Mar 18, 26 | Agmon Ido | other | 2,650,000 |
| Mar 18, 26 | Efron Gil | other | 0 |
| Mar 18, 26 | Efron Gil | other | 13,500,000 |
| Mar 18, 26 | Schickler Michael | other | 0 |
| Mar 18, 26 | Schickler Michael | other | 7,100,000 |
Our PPBT coverage
Recent articles, reports, and earnings notes.
No research on PPBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PPBT report →Similar companies
Peers in the same neighborhood.